#EloraTZP - Twitter Hashtag

about 11 hours ago

A new experimental weight-loss combination has delivered striking results in a Phase 2b clinical trial. #WeightLoss #EloraTZP #Tirzepatide #Eloralintide #GLP1 #GIP #Amylin #Obesity #Diabetes #alchetron #viral Read more : https://t.co/8aQRQqiT5A

0

84

GLP-1 LIFE! @GLP1_LIFE

4 days ago

#Obesity Meds watchlist, based on clinical efficacy, development stage, dosing advantages and how differentiated the drug is from #semaglutide #tirzepatide. #GLP1 #Retatrutide #Zenagmatide #VK2735 #EloraTZP #CagriSema #MariTide #Survodutide

GLP1_LIFE's tweet photo. #Obesity Meds watchlist, based on clinical efficacy, development stage, dosing advantages and how differentiated the drug is from #semaglutide #tirzepatide.
#GLP1 #Retatrutide #Zenagmatide #VK2735 #EloraTZP #CagriSema #MariTide #Survodutide https://t.co/2Z0ea0hSds

0

67

Ted Kyle @ConscienHealth

5 days ago

Does @EliLillyandCo have a winner in #EloraTZP for obesity in diabetes? Data from #EASD2026 suggests it might. https://t.co/zIZD5Pv9EO

ConscienHealth's tweet photo. Does @EliLillyandCo have a winner in #EloraTZP for obesity in diabetes? Data from #EASD2026 suggests it might.
https://t.co/zIZD5Pv9EO https://t.co/0nu6ujk1JM

0

11

6

0

415

Quartz @qz

5 days ago

Lilly's new drug combo beats Ozempic's rival — by a wide margin Eli Lilly's experimental EloraTZP helped patients lose 23% of their body weight — nearly 10 points more than tirzepatide alone — signaling a potential new ceiling for obesity treatme #EliLilly #EloraTZP #WeightLoss

qz's tweet photo. Lilly's new drug combo beats Ozempic's rival — by a wide margin

Eli Lilly's experimental EloraTZP helped patients lose 23% of their body weight — nearly 10 points more than tirzepatide alone — signaling a potential new ceiling for obesity treatme

#EliLilly #EloraTZP #WeightLoss https://t.co/oatcQB660G

1

0

737

GLP-1 LIFE! @GLP1_LIFE

6 days ago

Lilly says combo drug EloraTZP cut 23.3% of body weight vs 14.8% for Zepbound alone Lilly targets late-stage trial start for #EloraTZP in fourth quarter of 2026 #EliLilly #Tirzepatide #Eloralintide $LLY https://t.co/bYS2MHyxQt

GLP1_LIFE's tweet photo. Lilly says combo drug EloraTZP cut 23.3% of body weight vs 14.8% for Zepbound alone

Lilly targets late-stage trial start for #EloraTZP in fourth quarter of 2026 #EliLilly #Tirzepatide #Eloralintide $LLY
https://t.co/bYS2MHyxQt https://t.co/BqZUCad4c3

0

60

Henry Han

@HanCardiomd

6 days ago

#EloraTZP Phase 2b: #Eloralintide (selective amylin receptor agonist ) + #tirzepatide delivered up to 23.3% weight loss (54.1 lb) and −2.9% A1C at 48 weeks vs 14.8% (34.4 lb) and −2.4% A1C with tirzepatide 15 mg. ➡️ @EliLillyandCo plans to advance EloraTZP into Phase 3 in Q4 2026. #Obesity #Diabetes #GLP1 #Amylin @EASDnews https://t.co/NisRZjeepc

HanCardiomd's tweet photo. #EloraTZP Phase 2b: #Eloralintide (selective amylin receptor agonist ) + #tirzepatide delivered up to 23.3% weight loss (54.1 lb) and −2.9% A1C at 48 weeks vs 14.8% (34.4 lb) and −2.4% A1C with tirzepatide 15 mg.

➡️ @EliLillyandCo plans to advance EloraTZP into Phase 3 in Q4 2026.

#Obesity #Diabetes #GLP1 #Amylin

@EASDnews

https://t.co/NisRZjeepc

0

7

2

1

901

Top Tweets for #EloraTZP

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users